GlassScriptPhysician profile
Melinda S Brown
NPI 1942456272
$9,286.94
in general payments reported to CMS, 2019-2025
18 companies · $3,090 in 2025
The $3,090 reported for 2025 was more than what 88% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,332 · 2020: $415 · 2021: $274 · 2022: $925 · 2023: $1,773 · 2024: $1,478 · 2025: $3,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,341.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $3,550.58 | 2019-2025 | Biktarvy, Sunlenca, Descovy |
| Viiv Healthcare Company | $3,254.59 | 2019-2025 | Apretude, Cabenuva, Dovato |
| Allergan, INC. | $534.84 | 2019-2020 | |
| Theratechnologies INC. | $308.46 | 2025 | Egrifta, Trogarzo |
| Glaxosmithkline, LLC. | $300.84 | 2022-2023 | Bexsero, Shingrix |
| Merck Sharp & Dohme LLC | $287.67 | 2019-2025 | Pifeltro, Gardasil 9, Vaxelis |
| Novo Nordisk INC | $211.52 | 2022-2024 | Ozempic, Rybelsus |
| Emd Serono, INC. | $191.96 | 2024-2025 | |
| Exact Sciences Corporation | $143.47 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $115.26 | 2019-2023 | Mavyret |
| Pfizer INC. | $63.61 | 2019-2023 | |
| Lilly USA, LLC | $60.23 | 2023-2024 | Mounjaro |
| Genentech USA, INC. | $58.17 | 2020 | |
| Sanofi Pasteur INC. | $51.04 | 2019-2025 | |
| Napo Pharmaceuticals INC | $50.67 | 2024-2025 | Mytesi |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $50.48 | 2019-2023 | Immunocap |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.40 | 2020 | |
| Hologic Sales and Service, LLC | $24.15 | 2025 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melinda Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.